Cell cycle regulatory proteins in UVB-skin carcinogenes
UVB 皮肤致癌物中的细胞周期调节蛋白
基本信息
- 批准号:6868120
- 负责人:
- 金额:$ 12.37万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2003
- 资助国家:美国
- 起止时间:2003-04-21 至 2008-03-31
- 项目状态:已结题
- 来源:
- 关键词:SDS polyacrylamide gel electrophoresisautoradiographybasal cell carcinomacell cycle proteinscell linecyclin dependent kinasecyclinsgenetically modified animalsimmunoprecipitationkeratinocytelaboratory mousemolecular oncologynorthern blottingsphosphorylationpolymerase chain reactionprotein degradationprotein structure functionradiation carcinogenesissite directed mutagenesisskin neoplasmssquamous cell carcinomaubiquitinultraviolet radiationwestern blottings
项目摘要
DESCRIPTION (provided by applicant):
Basal Cell and squamous cell carcinomas (nonmelanoma skin cancers or NMSC) are the most common type of human malignancies with approximately one million new cases diagnosed annually in the United States. The vast majority of these tumors are the result of exposure to sunlight, particularly ultraviolet B (UVB) radiation. It is becoming increasingly clear that cell cycle regulators, including cyclin Dl, are potential targets for UVB-induced damages. We demonstrated that UVB irradiation of a transformed keratinocyte cell line lacking functional p53 results in cell cycle arrest in GI. This arrest coincided with the degradation of cyclin Dl and cdk4 proteins and was, in part, proteasome-dependent. This suggests that regulation of cyclin Dl protein stability is an early cellular response to UVB radiation. Furthermore, increased levels of cyclin Dl are found in various types of tumors. Indeed, our complete photocarcinogenesis study in a mouse model showed the early accumulation of cyclin Dl protein that increased gradually during UVB-induced skin carcinogenesis. Thus, regulation of cyclin Dl stability seems to be a key event of the short- and long-term responses to UVB radiation. We propose to study the mechanisms regulating cyclin Dl stability following U\JB radiation in cell lines and in mouse models for skin photocarcinogenesis. We will test the hypothesis that the mechanism(s) responsible for the rapid UVB-induced degradation of cyclin Dl are impaired in skin chronically exposed to UVB, thus participating in the accumulation of cyclin Dl leading to skin tumors formation. We anticipate that the combination of in vitro and in vivo approaches will help to better understand the molecular basis of skin cancer development. In addition, our studies could provide a rationale to develop new therapeutic tools targeted towards the protein degradation machinery.
描述(由申请人提供):
基底细胞癌和鳞状细胞癌(非黑色素瘤皮肤癌或NMSC)是最常见的人类恶性肿瘤类型,在美国每年诊断出约100万新发病例。这些肿瘤中的绝大多数是暴露于阳光,特别是紫外线B(UVB)辐射的结果。越来越清楚的是,包括细胞周期蛋白Dl在内的细胞周期调节因子是UVB诱导损伤的潜在靶点。我们证明,UVB照射的转化角质形成细胞系缺乏功能性p53的结果在GI细胞周期停滞。这种逮捕与细胞周期蛋白D1和cdk4蛋白的降解相一致,并且部分依赖于蛋白酶体。这表明细胞周期蛋白D1蛋白稳定性的调节是对UVB辐射的早期细胞反应。此外,在各种类型的肿瘤中发现细胞周期蛋白D1水平增加。事实上,我们在小鼠模型中进行的完整的光致癌研究表明,在UVB诱导的皮肤致癌过程中,细胞周期蛋白D1蛋白的早期积累逐渐增加。因此,调节细胞周期蛋白D1的稳定性似乎是UVB辐射的短期和长期反应的关键事件。我们建议研究调节细胞周期蛋白D1的稳定性的机制后,U\JB辐射在细胞系和小鼠皮肤光致癌模型。我们将检验这样的假设,即负责UVB诱导的细胞周期蛋白D1快速降解的机制在长期暴露于UVB的皮肤中受损,从而参与细胞周期蛋白D1的积累,导致皮肤肿瘤形成。我们预计体外和体内方法的结合将有助于更好地了解皮肤癌发展的分子基础。此外,我们的研究可以为开发针对蛋白质降解机制的新治疗工具提供理论基础。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
ARIANNA L KIM其他文献
ARIANNA L KIM的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('ARIANNA L KIM', 18)}}的其他基金
Chk2 as a target for regulating senescence in skin neoplasia
Chk2 作为调节皮肤肿瘤衰老的靶点
- 批准号:
7321973 - 财政年份:2007
- 资助金额:
$ 12.37万 - 项目类别:
Chk2 as a target for regulating senescence in skin neoplasia
Chk2 作为调节皮肤肿瘤衰老的靶点
- 批准号:
7460804 - 财政年份:2007
- 资助金额:
$ 12.37万 - 项目类别:
Cell cycle regulatory proteins in UVB-skin carcinogenes
UVB 皮肤致癌物中的细胞周期调节蛋白
- 批准号:
6668793 - 财政年份:2003
- 资助金额:
$ 12.37万 - 项目类别:
Cell cycle regulatory proteins in UVB-skin carcinogenes
UVB 皮肤致癌物中的细胞周期调节蛋白
- 批准号:
7055375 - 财政年份:2003
- 资助金额:
$ 12.37万 - 项目类别:
Cell cycle regulatory proteins in UVB-skin carcinogenes
UVB 皮肤致癌物中的细胞周期调节蛋白
- 批准号:
6740110 - 财政年份:2003
- 资助金额:
$ 12.37万 - 项目类别:
Cell cycle regulatory proteins in UVB-skin carcinogenes
UVB 皮肤致癌物中的细胞周期调节蛋白
- 批准号:
7234141 - 财政年份:2003
- 资助金额:
$ 12.37万 - 项目类别:
相似海外基金
Harnessing PET to Study the In Vivo Fate and Health Effects of Micro- and Nanoplastics
利用 PET 研究微塑料和纳米塑料的体内命运和健康影响
- 批准号:
10890903 - 财政年份:2023
- 资助金额:
$ 12.37万 - 项目类别:
Subtype-Selective Metabotropic Glutamate Receptor PET Ligands
亚型选择性代谢型谷氨酸受体 PET 配体
- 批准号:
10576674 - 财政年份:2023
- 资助金额:
$ 12.37万 - 项目类别:
Altered microglia states and microglia-endothelial cell axis in relation to white matter disease progression in VCID
VCID 中小胶质细胞状态和小胶质细胞内皮细胞轴的改变与白质疾病进展相关
- 批准号:
10738860 - 财政年份:2023
- 资助金额:
$ 12.37万 - 项目类别:
Circadian Rhythms in Blood Brain Barrier Permeability and Increased Efficacy of Chemotherapy for Brain Metastases
血脑屏障通透性的昼夜节律和脑转移化疗疗效的提高
- 批准号:
10663717 - 财政年份:2023
- 资助金额:
$ 12.37万 - 项目类别:
Glycogen synthase kinase 3 ligand discovery for Alzheimer’s disease
糖原合成酶激酶 3 配体发现治疗阿尔茨海默病
- 批准号:
10637434 - 财政年份:2023
- 资助金额:
$ 12.37万 - 项目类别:
Assessing Diffusion MRI Metrics for Detecting Changes of Synaptic Density in Alzheimer's Disease
评估弥散 MRI 指标以检测阿尔茨海默病突触密度的变化
- 批准号:
10739911 - 财政年份:2023
- 资助金额:
$ 12.37万 - 项目类别:
Safety/Toxicology, ADME and CMC Activities to Support the Assessment of the mGlu2 PAM SBP-9330 in a Phase 2 Clinical Study in Smokers
支持在吸烟者 2 期临床研究中评估 mGlu2 PAM SBP-9330 的安全性/毒理学、ADME 和 CMC 活动
- 批准号:
10829189 - 财政年份:2023
- 资助金额:
$ 12.37万 - 项目类别:
Probing D2 and 5HT-2A mechanisms in early visual processing in V1
探索 V1 早期视觉处理中的 D2 和 5HT-2A 机制
- 批准号:
10605769 - 财政年份:2023
- 资助金额:
$ 12.37万 - 项目类别:
Develop in vivo PET imaging probes for ROCK2 as a biomarker of early Alzheimer's disease.
开发 ROCK2 的体内 PET 成像探针作为早期阿尔茨海默病的生物标志物。
- 批准号:
489145 - 财政年份:2023
- 资助金额:
$ 12.37万 - 项目类别:
Operating Grants